Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Replimune Group, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 108 | 1 | 110 | +3 |
| Shares | 34.8M | 280.0K | 34.9M | +315.7K (+0.9%) |
| Value | $1.06B | $8.54M | $1.34B | +$283.8M (+26.9%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Replimune Group, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wellington Management Group LLP | 366,502 | $14.1M | 0.00% |
| Amundi | 273,695 | $10.5M | 0.01% |
| Invesco Ltd. | 116,784 | $4.49M | 0.00% |
| Alberta Investment Management Corp | 80,000 | $3.07M | 0.03% |
| Hennion & Walsh Asset Management, Inc. | 19,162 | $736.0K | 0.04% |
| Altshuler Shaham Ltd | 15,000 | $576.0K | 0.00% |
| AlphaCrest Capital Management LLC | 11,000 | $423.0K | 0.02% |
| Principal Financial Group Inc | 10,731 | $412.0K | 0.00% |
| DuPont Capital Management Corp | 9,323 | $358.0K | 0.01% |
| Blueshift Asset Management, LLC | 7,868 | $302.0K | 0.02% |
| ExodusPoint Capital Management, LP | 5,408 | $208.0K | 0.00% |
| Dark Forest Capital Management LP | 2,243 | $86.0K | 0.04% |
| Quantbot Technologies LP | 1,400 | $53.0K | 0.00% |
| FORA Capital, LLC | 1,034 | $40.0K | 0.01% |
| TCI Wealth Advisors, Inc. | 76 | $3.00K | 0.00% |
Sold out (12)
Institutions that held Replimune Group, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| First Manhattan Co | 146,272 | $4.46M |
| Cormorant Asset Management, LP | 125,000 | $3.81M |
| D. E. Shaw & Co., Inc. | 121,257 | $3.70M |
| Canada Pension Plan Investment Board | 60,000 | $1.83M |
| California Public Employees Retirement System | 42,400 | $1.29M |
| Allianz Asset Management GmbH | 41,055 | $1.25M |
| Qube Research & Technologies Ltd | 12,819 | $391.0K |
| Dynamic Technology Lab Private Ltd | 7,840 | $239.0K |
| Gsa Capital Partners LLP | 7,369 | $225.0K |
| Bank of Montreal | 2,512 | $77.0K |
| Pacer Advisors, Inc. | 2,288 | $70.0K |
| Sowell Financial Services LLC | 278 | $10.0K |
Not filed for Q2 2021 yet (1)
Institutions that held Replimune Group, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 280,014 | $8.54M |